Androgenetic Alopecia
📧 Sign up to get email alerts when something new happens for Androgenetic Alopecia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-04-27FDA Approved: MENS ROGAINE EXTRA STRENGTH UNSCENTED — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for MENS ROGAINE EXTRA STRENGTH UNSCENTED (minoxidil) by Kenvue Brands LLC. The approval covers labe…
-
FDA label_change · 2015-04-27FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Women's Rogaine Unscented (minoxidil) filed by Kenvue Brands LLC, authorizing labeling changes f…
-
FDA approval · 2015-04-09FDA Approved: MINOXIDIL — Supplemental Application (Endo USA, Inc.)
FDA approves a supplemental application for MINOXIDIL from Endo USA, Inc., updating the approved product information.
-
FDA approval · 2015-04-09FDA Approved: MINOXIDIL — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for Minoxidil (generic) submitted by Endo USA, Inc., for the approved generic product.
-
FDA approval · 2015-04-06FDA Approved: FINASTERIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for Finasteride (generic) under ANDA090061.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-03-19FDA Approved: FINASTERIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for Finasteride (generic), confirming approval of changes to the product. Fina…
-
CLINICAL_TRIALS research · 2015-03-19Clinical Trial Update: Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia [NA]
A clinical trial is assessing the efficacy of Platelet-Rich Plasma for androgenetic alopecia. The trial status is currently unknown.
-
FDA approval · 2015-03-13FDA Approved: MINOXIDIL — Supplemental Application (Walgreens)
FDA approved a supplemental application for MINOXIDIL from Walgreens, indicating approval of a supplemental filing for an existing generic p…
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia [Phase 3]
Phase 3 long-term study evaluating safety and efficacy of dutasteride in men with androgenetic alopecia has completed. Results were posted i…
-
FDA approval · 2015-02-10FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application to add an unscented formulation of Women's Rogaine containing minoxidil for female pattern hair loss…
-
FDA label_change · 2014-12-15FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Finasteride by Accord Healthcare, Inc., updating the drug's labeling. The supplement likely incl…
-
FDA approval · 2014-12-14FDA Approved: FINASTERIDE — Supplemental Application (Dr Reddys Laboratories Inc)
FDA approved a supplemental application for finasteride by Dr Reddys Laboratories Inc, enabling the generic product to be marketed under AND…
-
FDA approval · 2014-12-14FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for finasteride from Aurobindo Pharma Limited.
-
FDA approval · 2014-12-14FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for finasteride from Aurobindo Pharma Limited under an Abbreviated New Drug Application.
-
FDA approval · 2014-12-14FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for finasteride from Accord Healthcare, Inc., granting an approval to modify the product via a suppl…
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia [NA]
This document reports a clinical trial update on the efficacy and safety of platelet-rich plasma for androgenetic alopecia.
-
FDA label_change · 2014-11-28FDA Approved: MINOXIDIL — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for MINOXIDIL from Endo USA, Inc., updating the labeling for the treatment of androgenetic alopecia.
-
FDA approval · 2014-11-03FDA Approved: FINASTERIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for finasteride by Sun Pharmaceutical Industries, Inc. (ANDA090508). This action grants approval for…
-
FDA approval · 2014-09-26FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for finasteride submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-09-21FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Finasteride submitted by Dr. Reddy's Laboratories Limited. This action refers to a supplemental …
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Topical Bimatoprost Effect on Androgen Dependent Hair Follicles [Phase 2]
Phase 2 study completed evaluating topical bimatoprost for androgenetic alopecia (male pattern hair loss); results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Clinical Trial in Females for Female Pattern Hair Loss [Phase 3]
Phase 3 trial in women with female pattern hair loss has completed and results were posted in 2014. Sponsor: Johnson & Johnson Healthcare Pr…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia [Phase 1]
Phase 1 clinical trial update evaluating microneedling for androgenetic alopecia; no efficacy data is provided in the document.
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Clinical Trial in Females With Female Pattern Hair Loss [Phase 3]
Phase 3 trial in women with female pattern hair loss has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia [Phase 2]
Phase 2 study evaluating the safety and effectiveness of bimatoprost for androgenetic alopecia in men has completed with results posted.